Evidence map›Paper›PMID 22013453›Full record

ArticleJournal of allergy2011

IL-17F Induces CCL20 in Bronchial Epithelial Cells.

Kyoko Nozato, Junichi Fujita, Mio Kawaguchi, Gen Ohara, Yuko Morishima, Yukio Ishii, Shau-Ku Huang, Fumio Kokubu, Hiroaki Satoh, Nobuyuki Hizawa

Open access · hybridAbstract read
In one paragraph

Article in Journal of allergy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Transcription Factor EepR Is Required forAntibiotics (Basel, Switzerland) · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Immune response to intrapharyngeal LPS in neonatal and juvenile mice.American journal of respiratory cell and molecular biology · 2015
    Article
  10. Potential involvement of IL-17F in asthma.Journal of immunology research · 2014
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kyoko NozatoDepartment of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.
Junichi Fujita
Mio Kawaguchi
Gen Ohara
Yuko Morishima
Yukio Ishii
Shau-Ku Huang
Fumio Kokubu
Hiroaki Satoh
Nobuyuki Hizawa
University of Tsukuba · JPJohns Hopkins University · USShowa University Fujigaoka Hospital · JP

Funding

Immunogenetic Analysis of Immune Response to AllergensR01AI052468 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HUANG, SHAU-KU · 2003 to 2012
$3.5M
Role of C-type lectin receptors in food allergyR21AI073610 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HUANG, SHAU-KU · 2007 to 2008
$448k
NIAID NIH HHS R01 AI052468NIAID NIH HHS R21 AI073610
6 · The paper itself

Abstract

IL-17F plays a crucial role in airway inflammatory diseases including asthma, but its function has not been fully elucidated. CCL20 is also involved in allergic airway inflammation, while its regulatory mechanisms remain to be defined. To further identify a novel role of IL-17F, the expression of CCL20 by IL-17F in bronchial epithelial cells and the signaling mechanisms involved were investigated. Bronchial epithelial cells were stimulated with IL-17F, and the levels of CCL20 gene and protein measured, with the effects of the addition of various kinase inhibitors and siRNAs also investigated. IL-17F significantly induced the expression of CCL20 gene and protein. Pretreatment with inhibitors for MEK1/2, Raf1 and MSK1, and overexpression of a Raf1 dominant-negative mutant significantly diminished IL-17F-induced CCL20 production. Moreover, transfection of the siRNAs targeting MSK1, p90RSK, and CREB blocked CCL20 expression. These findings suggest that IL-17F is able to induce CCL20 via Raf1-MEK1/2-ERK1/2-MSK1/p90RSK-CREB signaling pathway in bronchial epithelial cells. The IL-17F/CCL20 axis may be a novel pharmacological target for asthma.

Identifiers

PMID22013453
PMCPMC3195431
OpenAlexW2019403353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.